Peter Gray (bioengineer)
Peter Gray | |
---|---|
Born | 1946 Australian |
Alma mater | University of Sydney (BA) University of New South Wales (PhD) |
Known for |
|
Scientific career | |
Fields | Biotechnology |
Institutions |
|
Thesis | (1970) |
Doctoral students |
Professor Peter Gray (born in Sydney in 1946) is a
Biography
Gray completed his university studies at
Gray undertook postdoctoral research as a Science Research Fellow at
After five years overseas, Gray returned to Australia in 1975 to take up an academic position in the School of Biotechnology at UNSW, where his research resulted in the development of novel cyclic fed –batch bioprocesses for antibiotic production which markedly extended the productivity of the cultures. Gray returned to the US in 1982 where he worked for the
On returning to UNSW, Gray introduced research to Australia into the use of mammalian cell cultures such as
In 1988 he was appointed as Professor of Biotechnology and Head of the Department of Biotechnology at UNSW, positions that he held for over fourteen years, and led this department to be the national research leader in the field. He established and was Director of, the Bioengineering Centre at UNSW.
In 1992 Gray became a Fellow of the
He serves on the Boards of: BioPharmaceuticals Australia Pty Ltd;
Australian Institute for Bioengineering and Nanotechnology (AIBN)
In 2003 Gray was appointed the Inaugural Director of the Australian Institute for Bioengineering and Nanotechnology (AIBN) and Professor of Bioengineering by
Research
Gray has been leading figure of antibody development using mammalian cell lines and stem cell bioprocesses.[11][12]
His work helped to lure attract AUD$17 million in
Gray has also helped to manufacture an antibody against
References
- ^ "UQ appoints first director of new high-tech institute". The University of Queensland. 27 June 2003. Retrieved 6 October 2015.
- ^ "Institute to welcome new director". The University of Queensland. 8 September 2015. Retrieved 6 October 2015.
- ^ "About Us". Engineers Australia. Retrieved 6 October 2015.
- ^ "AusBiotech in search of past Presidents". AusBiotech. AusBiotech. Retrieved 15 September 2015.
- ^ "Professor Peter Gray". BioPharmaceuticals Australia. BioPharmaceuticals Australia. Retrieved 15 September 2015.
- ^ "ECI Board Members". Engineering Conferences International. Engineering Conferences International. Retrieved 15 September 2015.
- ^ "About Us People". ACYTE Biotech. ACYTE Biotech. Retrieved 15 September 2015.
- ^ "Professor Peter Gray". University of Queensland Diamantina Institute. University of Queensland Diamantina Institute. Retrieved 15 September 2015.
- ^ "Professor Peter Gray". Australian Institute for Bioengineering and Nanotechnology. Australian Institute for Bioengineering and Nanotechnology. Retrieved 15 September 2015.
- ^ "UQ tech institute picks director". Campus Review. Retrieved 6 October 2015.
- ^ O'Neill, Graeme (19 September 2005). "Nanotech medicine tailored for individuals". The Age. Retrieved 6 October 2015.
- ^ Wylie, Fiona (20 December 2010). "Feature: Manufacturing monoclonal antibodies". Australian Life Scientist. Retrieved 6 October 2015.
- ^ Dean, Tim (9 December 2011). "DSM Biologics and AIBN partner to open biologics facility in Queensland". Australian Life Scientist. Retrieved 6 October 2015.
- ^ "Premier announces new collaboration for Queensland Biotechnology" (PDF). Queensland Government. Retrieved 6 October 2015.
- ^ "Queenslanders commit to fight against Hendra". Queensland Health. 1 April 2015. Retrieved 6 October 2015.
- ^ "World-First Human Hendra Virus Clinical Trials Begin". Drug Discovery & Development Magazine. 4 August 2015. Retrieved 6 October 2015.
- ^ "Queensland tapped by US to develop MERS-CoV antibody". Queensland Health. 5 June 2015. Retrieved 6 October 2015.